ANB-504

N/A

Report date: 2022/06/30 14:39:34
NME

Base Information

Drug NameANB-504
Drug Alias NameANB-504
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channels blockers
TargetsSodium channels
Therapy Area/IndicationsInflammationNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAnabios Corp
China Registration ClassN/A

Develop Information

Active CompaniesAnabios Corp
Inactive CompaniesN/A
Active IndicationsInflammationNeuralgia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A